Literature DB >> 15122598

Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers.

Akihiko Okayama, Sherri Stuver, Masao Matsuoka, Junzo Ishizaki, Gen-Ichi Tanaka, Yoko Kubuki, Nancy Mueller, Chung-Cheng Hsieh, Nobuyoshi Tachibana, Hirohito Tsubouchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15122598     DOI： 10.1002/ijc.20144

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  36 in total

1.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

2.  Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

Authors:  Yoshimi Enose-Akahata; Anna Abrams; Kory R Johnson; Elizabeth M Maloney; Steven Jacobson
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

3.  Establishment of a simplified inverse polymerase chain reaction method for diagnosis of enzootic bovine leukosis.

Authors:  Asami Nishimori; Kiyohiko Andoh; Yuichi Matsuura; Asuka Kumagai; Shinichi Hatama
Journal:  Arch Virol       Date:  2021-01-24       Impact factor: 2.574

4.  Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma.

Authors:  Andrew Hodson; Daniel J Laydon; Barbara J Bain; Paul A Fields; Graham P Taylor
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

5.  Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia.

Authors:  Sanaz Firouzi; Amir Farmanbar; Kenta Nakai; Masako Iwanaga; Kaoru Uchimaru; Atae Utsunomiya; Yutaka Suzuki; Toshiki Watanabe
Journal:  Blood Adv       Date:  2017-06-27

6.  Route of primary HTLV-1 infection regulates HTLV-1 distribution in reservoir organs of infected mice.

Authors:  Masakazu Tanaka; Takayuki Nitta; Binlian Sun; Jun-Ichi Fujisawa; Masanao Miwa
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

7.  Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders.

Authors:  Kazuko Azakami; Tomoo Sato; Natsumi Araya; Atae Utsunomiya; Ryuji Kubota; Kenshi Suzuki; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Ryoji Fujii; Naoko Yagishita; Hajime Kamijuku; Takuro Kanekura; Ken-ichiro Seino; Kusuki Nishioka; Toshihiro Nakajima; Yoshihisa Yamano
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

8.  Altered Expression of Cell Cycle Regulators in Adult T-Cell Leukemia/ Lymphoma Patients.

Authors:  Reza Torshizi; Ehsan Ghayour Karimani; Kobra Etminani; Mohammad Mehdi Akbarin; Khadijeh Jamialahmadi; Abbas Shirdel; Hossein Rahimi; Abolghasem Allahyari; Amin Golabpour; Houshang Rafatpanah
Journal:  Rep Biochem Mol Biol       Date:  2017-10

9.  High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders.

Authors:  Daisuke Sasaki; Yuko Doi; Hiroo Hasegawa; Katsunori Yanagihara; Kunihiro Tsukasaki; Masako Iwanaga; Yasuaki Yamada; Toshiki Watanabe; Shimeru Kamihira
Journal:  Virol J       Date:  2010-04-28       Impact factor: 4.099

10.  Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.

Authors:  Yoshihisa Yamano; Natsumi Araya; Tomoo Sato; Atae Utsunomiya; Kazuko Azakami; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Naoko Yagishita; Ryoji Fujii; Kusuki Nishioka; Steven Jacobson; Toshihiro Nakajima
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.